SCHEMBL6582509

SCHEMBL6582509

CN(c1ccc(C(=O)OC(C)(C)C)cc1)C1CCc2cc3nc(CN4CCCCC4)n(C)c(=O)c3cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.38
NPC1 O15118 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.34
CYP2D6 P10635 1/20 0.34
THRB P10828 1/20 0.34
CYP2C19 P33261 1/20 0.34
NAMPT P43490 4/20 0.34
ALDH1A1 P00352 5/20 0.34
MAPK1 P28482 1/20 0.34
KDM4E B2RXH2 1/20 0.33
MAPT P10636 2/20 0.33
KDM1A O60341 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
USP2 O75604 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6582772 0.89 HDAC6 (0.41) HDAC6NPC1SMN1; SMN2POLBCYP3A4
SCHEMBL6580579 0.85 SMN1; SMN2 (0.41) SMN1; SMN2POLBGAATHRBALDH1A1
SCHEMBL6585879 0.83 GPR119 (0.31)
SCHEMBL6582588 0.77 ELANE (0.30)
SCHEMBL6583698 0.76 PARP14 (0.35) ALDH1A1MAPTMEN1KMT2A
SCHEMBL6905953 0.73 SMN1; SMN2 (0.42) SMN1; SMN2POLBGAATHRBALDH1A1
SCHEMBL6585873 0.73 PARP14 (0.34) ALDH1A1MAPTMEN1KMT2A
SCHEMBL6584349 0.73 NAMPT (0.61) HDAC6SMN1; SMN2POLBCYP3A4GAA
SCHEMBL6585453 0.72 NAMPT (0.61) NAMPTALDH1A1
SCHEMBL6585952 0.72 TRPM8 (0.34) HDAC6THRBALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1155012-B1 ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES CANCER REC TECH LTD (GB) 2004-04-14 EP disclosed
US-6699861-B1 ANTI-CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2004-03-02 US disclosed
EP-1155012-A1 ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES Cancer Research Ventures Limited (GB) 2001-11-21 EP disclosed
WO-2000050417-A1 ANTI-CANCER DIHYDROQUINAZOLINE DERIVATIVES CANCER RESEARCH VENTURES LIMITED (GB) 2000-08-31 WO disclosed